WeedLife News Network

Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.

Despite health risks, the use of this sleeping aid has increased over the years

Even though melatonin is an over-the-counter medicine, not enough is known about it for people to be consuming it so comfortably.

Sleep disorders are incredibly common, affecting about 70 million Americans a year. Medications and other substances that treat sleep are increasingly common, although with some concerning side effects that might impact sleep in the long term.

One of the most harmless solutions to this is melatonin, a compound that’s been growing in popularity over the years. Still, when used at high levels, it has a certain amount of risks.

According to a new study, melatonin use has increased over the past few years, increasing by more than twice the amount consumed a decade ago.

The study, published in JAMA Network, argues that even though melatonin is an over-the-counter medicine, not enough is known about it for people to be consuming it so comfortably. Despite the fact that people view it as a natural herb, the reality is that melatonin is a hormone. The consumption of it is so widespread that companies advertising it as a sleep aid vary wildly in the amount of melatonin per gram, at times providing more than the standard 5mg a day dosage that’s recommended for providing quick relief in sleep problems.

According to the NIH, melatonin has been linked with headaches, dizziness, nausea, irritability, anxiety and depression, and is capable of interacting with other medications. “We cannot be certain of the purity of melatonin that is available over the counter,” sleep specialist Rebecca Robbins told CNN.

While it appears that in the short term melatonin provides useful benefits, its long-term use is much more complex than a harmless pill that can put you to bed.

e-mail icon
Continue reading

The exploding health benefits of CBD + adaptogens

The benefits of CBD as well as adaptogens clearly fill a massive void in western medicine so it’s not surprising to see patients fall for their charms.

Cannabidiol (CBD) may seem like it’s been a hot topic on the wellness front for quite some time now. After all, the non-psychoactive compound of marijuana has touted for its stress and anxiety-relieving properties without getting you high. It has a cult following, and for good reason — there’s a lot of data and evidence that CBD does work. It’s everywhere these days, from CBD capsules to oils, beverages and edibles, getting rid of stress has never been easier.

But sharing the limelight with CBD these days are adaptogens.

Adaptogens have been known for hundreds of years, especially in Asia and India, and among those who follow Ayurvedic lifestyle principles. They refer to types of plants that possess special properties to help the body cope with stress, regulate healthy functioning and hormonal balance. Aside from that, they have numerous other health benefits such as help fighting off fatigue, reduce inflammation, improve sleep, and improve cognitive function even when we are under periods of stress among others.

Benefits of Combining CBD and Adaptogens

Popular and common adaptogens that you’ll easily encounter in the market are the following:

Ashwagandha: Widely used for centuries to treat stress and anxiety, and its use in ayurvedic potions. Ashwagandha is a root that is also used in some eastern delicacies.

e-mail icon
Continue reading

Mums-to-be who smoke cannabis during pregnancy ‘double risk of stunting baby’s growth’

Women who smoke cannabis during pregnancy double the risk of stunting their baby’s growth, a study warns.

Risks of premature birth, lower birth weight and possible low intelligence in later life were all increased. The report came from data on 60,000 mothers in the US, Canada and Jamaica in 16 studies. Chances of newborns being small for their age rose by 61 per cent for cannabis users. And the risk of being born premature went up by 28 per cent. Scores given to newborns that assess pulse, breathing and reactions also fell by 26 per cent, the Marchand Institute for Minimally Invasive Surgery, US, found. Dr Greg Marchand said: “Women exposed to marijuana in pregnancy were at a significantly increased risk of adverse neonatal outcomes.

“Given increasing marijuana legalisation and use worldwide, raising awareness and educating patients about these adverse outcomes may help to improve neonatal health.”

Rate this article: 
Select ratingGive Mums-to-be who smoke cannabis during pregnancy ‘double risk of stunting baby’s growth’ 1/5Give Mums-to-be who smoke cannabis during pregnancy ‘double risk of stunting baby’s growth’ 2/5Give Mums-to-be who smoke cannabis during pregnancy ‘double risk of stunting baby’s growth’ 3/5Give Mums-to-be who smoke cannabis during pregnancy ‘double risk of stunting baby’s growth’ 4/5Give Mums-to-be who smoke cannabis during pregnancy ‘double risk of stunting baby’s growth’ 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

Survey reveals risks, rewards of cannabis use

Some people with Parkinson’s disease find that using cannabis products helps to ease certain symptoms, according to results from a survey.

The findings notably suggest that cannabis products with high levels of the chemical THC are more likely to induce both positive and negative effects in Parkinson’s patients.

“These survey results offer a broad overview of real-world cannabis use patterns and experience among a large group of people living with [Parkinson’s] and provide initial results regarding the differential symptomatic effects of” different cannabis products, researchers wrote.

Findings were published in the study, “Higher risk, higher reward? Self-reported effects of real-world cannabis use in Parkinson’s disease,” in Movement Disorders.

 

Cannabis has two main active components: tetrahydrocannabinol (THC), which is the main chemical that induces a “high,” and cannabidiol (CBD), which doesn’t induce a “high” but may have numbing or anti-inflammatory properties.

e-mail icon
Continue reading

New Medical Cannabis Program goes into effect across the state

This expands the eligibility criteria for patients who can benefit from medical cannabis and makes it easier for them to be certified by a medical practitioner.

A new Medical Cannabis Program certification and registration system went into effect on Monday across the state. 

This expands the eligibility criteria for patients who can benefit from medical cannabis and makes it easier for them to be certified by a medical practitioner.

Last year's marijuana regulation and taxation act ensured that this new system will be run by the office of cannabis management instead of the health department.

“It is terrific to see the Medical Cannabis Program expand so vastly with the launch of the new certification and registration program and the ability of practitioners to determine qualifying conditions as included in the MRTA,” said Cannabis Control Board Chair Tremaine Wright. 
 
“The new cannabis industry is taking shape as we continue to implement the MRTA and provide greater access for New Yorkers to a medicine that we’re learning more about every day. We’re continuing to move forward swiftly and today’s system launch follows our achievements that already include adding whole flower medical product sales, permanently waiving $50 patient fees, and advancing home cultivation regulations, among others.”

The program was first proposed back in October.

Patients who are certified through the new certification and registration system will be issued a new certification from the New York State Office of Cannabis Management after the current one expires.

e-mail icon
Continue reading

Does cannabis cause psychosis? A new study sheds some light

Responsible parties should inform consumers, especially teens, about the harms of cannabis and the serious conditions that may arise from abusing the substance.

One of marijuana’s most concerning connections is the one it has with psychosis. While not wholly understood, this link has been reported to be significant, with several studies indicating that people who smoke large amounts of weed on a daily basis are five times more likely to develop psychosis than others. This depends on the age at which marijuana is first consumed and the individual’s genetic vulnerabilities.

Now, a new study provides some much-needed information and context on the topic.
 
Published in the American Journal of Psychiatry, the study looked into the connection between schizophrenia and cannabis and tried to provide answers to a question that has long been unanswered: Does cannabis use cause schizophrenia, or are people who suffer from schizophrenia more likely to seek out the drug?
 
The study looked into young subjects, all within the ages of 13 to 16, who filled out annual self-reports of past-year cannabis use and psychotic symptoms.
 
The findings spotted clear links between frequent cannabis use and more psychotic symptoms. Subjects who reported cannabis use in the previous year were more likely to experience psychotic symptoms a year afterward.
 
Still, the finding is not necessary foolproof evidence of causation. Many more studies need to be conducted to have a better understanding of the issue, and to know how to address it properly, especially in the case of children and teens, who are at higher risk for harm when exposing their young brains to cannabis.
 
While studies like this can be scary for cannabis proponents, they are necessary for having a thorough understanding of the plant.
 
As cannabis gets legalized across U.S. states, responsible parties should inform consumers, especially teens, about the harms of cannabis and the serious conditions that may arise from abusing the substance.
 
Most people can use cannabis safely. Still, that doesn’t mean everyone should turn a blind eye to those who are exposed to greater risks.
 
 
Rate this article: 
Select ratingGive Does cannabis cause psychosis? A new study sheds some light 1/5Give Does cannabis cause psychosis? A new study sheds some light 2/5Give Does cannabis cause psychosis? A new study sheds some light 3/5Give Does cannabis cause psychosis? A new study sheds some light 4/5Give Does cannabis cause psychosis? A new study sheds some light 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

4 things to know about Delta-8-THC, the new cannabis drug

 

New studies: Survey of user experience and warnings of unregulated contaminants.

The sudden appearance of delta-8-tetrahydrocannabinol (delta-8-THC, or delta-8) and its quick rise in popularity is a classic tale of unintended consequences and loopholes that enterprising entrepreneurs rush through.

 

1. Delta-8 is a cannabinoid molecule naturally found in cannabis.

The cannabis plant contains over 100 similar molecules called cannabinoids, most of them in small quantities and with unknown properties. Delta-9-tetrahydrocannabinol, commonly called THC, is the most abundant and most psychoactive molecule in popular strains of marijuana. When the double bond between two carbon atoms shifts location slightly, it creates delta-8, which has similar effects as delta-9 but is only two-thirds as strong. Until recently, delta-8 was little known because cannabis plants contain only .1 percent delta-8, which is too little to extract profitably.

2. Delta-8 is legal and unregulated.

The 2018 Farm Bill legalized industrial hemp products as long as the delta-9 content remained below .3 percent. This bill permitted a great increase in the production of CBD (cannabidiol), which exists in sufficient amounts in hemp to be extracted profitably. When over-production of CBD created a glut that plummeted prices in 2020, the industry began looking for innovative ways to make the excess CBD profitable. Simple chemistry discovered in the 1960s using solvents like toluene began being used to convert CBD into delta-8.

Since the Farm Bill said nothing specific about delta-8, it remained legal federally, and only 14 states have restricted its sale to date. Able to be offered on the Internet, mailed through the US Postal Service, and sold in gas stations, convenience stores, and cannabis dispensaries, it has been the fastest-growing segment of the hemp-derived market this last year, says Ian Laird of data analytics company Hemp Benchmarks.

e-mail icon
Continue reading

CBD for sleep: CBN competes with Ambien and Melatonin

The hemp industry has been unloading products containing new alternative cannabinoids targeting specific moods and providing more benefits. One of the cannabinoids increasing in popularity is called CBN (Cannabinol), also known as the CBD for sleep.

CBN is a cannabinoid found in, and derived from, the hemp plant. Although close in chemical structure to CBD, the compounds produce very different results. CBN is specifically for getting to sleep, staying asleep and for anti-anxiety.

What is CBN?

Cannabinol, the scientific name for CBN, has been the newest upcoming cannabinoid and consumers have been flocking to it due to its sleep and relaxing properties.

CBN is created naturally due to the degradation of Delta 9 THC. Because of the technology that hemp companies have been able to scale, this magical cannabinoid can now be adopted at scale by consumers.

What is the difference between CBN and CBD?

Due to the fact that the hemp industry is discovering more potent benefits the alternative cannabinoids are offering, CBD has been slowly fading out into the background due to its lack of strength in benefits compared to CBN and others.

e-mail icon
Continue reading

Medical cannabis expansion launches in Utah

An expansion to Utah's medical cannabis program has officially launched, allowing more health care workers to recommend marijuana to qualifying patients.

The program allows any licensed physician, physician's assistant, nurse or podiatrist with a controlled substance license to recommend cannabis to up to 15 patients. There are more than 21,000 medical providers who can now recommend medical cannabis, the Utah Department of Health said.

"This program expands access to medical cannabis for qualifying patients by increasing the number of clinicians who have the option to recommend medical cannabis. In the past, adult patients had to obtain a recommendation from one of the 800 medical providers who were registered with the Utah Department of Health but that is no longer the case," Richard Oborn, Utah Department of Health's Center for Medical Cannabis director, said in a statement.

FOX 13 first reported in 2019 about problems qualifying patients were having getting a physician willing to recommend. The Utah State Legislature created the "limited medical provider" option to get health care workers more comfortable with cannabis.

The expansion was supposed to launch last October, but staffing and technology issues delayed it. Lawmakers, caught off guard by the delay, were not pleased and demanded timelines be sped up. Patient advocates were also frustrated.

e-mail icon
Continue reading

Marijuana edibles spurring rise in pot-related overdose calls to Illinois Poison Center

Marijuana edibles are becoming increasingly popular, but doctors warn the substances are prone to accidental consumption or may pack too much of a wallop for new users.

Newly released numbers show marijuana overdose-related calls in Illinois jumped significantly after legalization, mainly due to edibles — but remained far below the number of calls for other legal drugs, including alcohol.

The number of calls to the Illinois Poison Center for cannabis rose from 487 in 2019, to 743 in 2020, the year recreational weed was legalized in the state, and increased again to 855 in 2021.

Many of the calls were for consumption of edibles, officials said. Edible cases more than tripled from 80 cases in 2019 to 450 in 2021.

“Looking at the reason for exposure, almost all were unintentional,” said Dr. Michael Wahl, medical director of the poison center.
 
“People didn’t mean to eat them, or didn’t know what they were eating.”
 
Most regular consumers of cannabis have a better idea of what to expect and don’t call the center, he said.

Many of the calls are for children. Calls to the poison center increased for children 5 and under from 81 in 2019, to 278 in 2021.

Some calls involve visitors, such as grandparents or babysitters, to a home where they came across edibles, Wahl said. About two-thirds of the calls came from health care facilities looking for advice on how to treat marijuana intoxication. Most cases were not severe and were resolved over the phone, but some required hospitalization until the effects wore off.
 
Symptoms of severe THC poisoning can include respiratory distress, loss of coordination, lethargy and loss of consciousness, or in milder cases, anxiety, paranoia and heart palpitations. The effects depend largely on the amount consumed compared to body weight, which is why children can have more severe reactions.
 
Edibles avoid the harmful effects on the lungs from smoking pot, but may have more variable amounts of THC, the main psychoactive component in cannabis, and may take an hour or two to fully kick in, prompting some impatient users to take too much. As a result, cannabis companies advocate starting with low doses and taking time to see their effects.
 
Despite the increases, the number of cannabis-related cases pales in comparison to the thousands of calls for other legal drugs such as pain killers, cleaning products, sedatives and antipsychotics, cosmetics, antidepressants and alcohol. Out of more than 80,000 calls to the poison center last year, 33,000 were for children under 5, so cannabis accounted for fewer than 1% of those calls.
 
Treatment often involves keeping the person calm and under observation, the center’s medical director said. All the cannabis patients fully recovered. Much bigger concerns, Wahl said, are drug interactions with alcohol, and the increase in fentanyl poisonings, including in counterfeit pills and in illegal cannabis.
 
No calls to the poison center involving cannabis have been fatal, but authorities warn that the drug may worsen the effects of other, potentially fatal substances.
 
Kevin Sabet, president of Smart Approaches to Marijuana, which opposes legalization, called the increase in cases an emergency.
 
“We need lawmakers to act now to restrict the potency of marijuana products,” he wrote in an email, “enact education campaigns on the dangerousness of today’s marijuana, and limit the influence of the marijuana industry in the state in general.”
 
The poison center doesn’t keep track of whether calls were for legal or illegal cannabis. But Pam Althoff, executive director of the Cannabis Business Association of Illinois, said unregulated cannabis products such as hemp-derived Delta-8-THC “weed light” and the highly potent THC-0 are more concerning than licensed, regulated cannabis, because consumers don’t know what they’re getting with such gray-market products sold in gas stations.
 
“I don’t see the need for more regulations (on legal edibles),” she said, “I see the need for more education.”
 
Despite the increase in cannabis use calls, another fear about legalization causing increased use among teens so far appears to have not panned out.
 
Adolescent cannabis use nationwide decreased significantly in 2021, according to the 2021 Monitoring the Future survey produced by the National Institute on Drug Abuse. The declines in teen drug use overall, thought to be related to restrictions prompted by the COVID pandemic, were the greatest since the survey began in 1975.
 
In addition, a prominent local treatment center for drug abuse, Rosecrance Health Network, has not seen a marked increase in long-term cannabis use disorder by itself, said Chief Medical Officer Dr. Tom Wright. 
 
“With adults, we’re noticing the trend that cannabis use tends to be combined with other substances, such as alcohol,” he said. “We do anticipate a growing need for cannabis treatment as use continues to become more common."
Rate this article: 
Select ratingGive Marijuana edibles spurring rise in pot-related overdose calls to Illinois Poison Center 1/5Give Marijuana edibles spurring rise in pot-related overdose calls to Illinois Poison Center 2/5Give Marijuana edibles spurring rise in pot-related overdose calls to Illinois Poison Center 3/5Give Marijuana edibles spurring rise in pot-related overdose calls to Illinois Poison Center 4/5Give Marijuana edibles spurring rise in pot-related overdose calls to Illinois Poison Center 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

Using marijuana may affect your ability to think and plan, study says

Remember those classic stoner dudes -- Cheech and Chong, anyone? -- spending their days in a weed-drenched room (or car), capable of little besides finding that next great high?

Weed can affect your ability to make decisions, solve problems and perform other cognitive functions, a study found.
 
If you don't, that's not surprising. As more and more states move to legalize marijuana, the stereotypical mind-numbing effects of weed have become passé, often replaced by an acceptance of the drug as an acceptable way to socialize, relax and get better sleep.
But while society may have forgotten the impact that weed can have on the brain, science has not.
 
Studies have long shown that getting high can harm cognitive function. Now, a new review of research, published Thursday in the journal Addiction, finds that impact may last well beyond the initial high, especially for adolescents.
"Our study enabled us to highlight several areas of cognition impaired by cannabis use, including problems concentrating and difficulties remembering and learning, which may have considerable impact on users' daily lives," said coauthor Dr. Alexandre Dumais, associate clinical professor of psychiatry at the University of Montreal.
 
"Cannabis use in youth may consequently lead to reduced educational attainment, and, in adults, to poor work performance and dangerous driving. These consequences may be worse in regular and heavy users," Dumais said.
Weed's impact on the brain can be particularly detrimental to cognitive development for youth, whose brains are still developing, said Dr. Megan Moreno, a professor of pediatrics at the University of Wisconsin School of Medicine and Public Health, who was not involved in the study.
 
"This study provides strong evidence for negative cognitive effects of cannabis use, and should be taken as critical evidence to prioritize prevention of cannabis use in youth," Moreno said.
 
"And contrary to the time of Cheech and Chong, we now know that the brain continues to develop through age 25.
 
"Parents should be aware that adolescents using cannabis are at risk for damage to their most important organ, their brain."
 

Higher-level thinking

 
The newly published review looked at studies on over 43,000 people and found a negative impact of tetrahydrocannabinol or THC, the main psychoactive compound in cannabis, on the brain's higher levels of thinking.
 
Those executive functions include the ability to make decisions, remember important data, plan, organize and solve problems, as well as control emotions and behavior.
 
Can you recover or reverse those deficits? Scientists aren't sure.
 
"Research has revealed that THC is a fat-soluble compound that may be stored in body fat and, thus, gradually released into the bloodstream for months," Dumais said, adding that high-quality research is needed to establish the long-term impact of that exposure.
 
Some studies say the negative effects on the brain may ease after weed is discontinued, but that may also depend on the amount, frequency and years of marijuana use. The age in which weed use began may also play a role, if it falls within the crucial developmental period of the youthful brain.
 
"Thus far, the most consistent alterations produced by cannabis use, mostly its chronic use, during youth have been observed in the prefrontal cortex," Dumais said. "Such alterations may potentially lead to a long-term disruption of cognitive and executive functions."

In addition, some studies have shown that "early and frequent cannabis use in adolescence predicts poor cognition in adulthood," he added.

While science sorts this out, "preventive and interventional measures to educate youths on cannabis use and discourage them from using the substance in a chronic manner should be considered ... since youths remain particularly susceptible to the effects of cannabis," Dumais said.
Rate this article: 
Select ratingGive Using marijuana may affect your ability to think and plan, study says 1/5Give Using marijuana may affect your ability to think and plan, study says 2/5Give Using marijuana may affect your ability to think and plan, study says 3/5Give Using marijuana may affect your ability to think and plan, study says 4/5Give Using marijuana may affect your ability to think and plan, study says 5/5
Authored By: 
Article category: 
Regional Marijuana News: 

e-mail icon

Reasons doctors prescribe marijuana most

Six reasons why doctors recommend using marijuana, according to experts.

​​There's been plenty of evidence that finds using marijuana for certain medicinal purposes is highly beneficial. It's proven to be helpful for patients who experience seizures, have autism, severe nausea or vomiting caused by cancer treatment, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), HIV/AIDS, Crohn's disease, epilepsy and seizures, glaucoma, multiple sclerosis and muscle spasms, among other medical conditions. In addition, doctors are suggesting marijuana for other reasons and Eat This, Not That! Health talked to experts who explained the reasons marijuana is prescribed the most. (NOTE: In order to responsibly use marijuana for medicinal purposes, do not use unless under the care of a medical professional guiding its use, know how to legally obtain marijuana and familiarize yourself with what the laws are regarding its use and purchase.) 

1. Pain

Dr. Tom Ingegno DACM, MSOM, LAC says, "Pain is probably the number one reason anyone recommends cannabis. Pain is a symptom of many different issues and diseases, not just injuries.  Due to cannabis's ability to reduce inflammation, it can be used for everything from arthritis to intractable cancer pain.  With a big national push to move away from opiates, doctors have been looking at other sources for pain relief and cannabis fits the bill."

2. Stress

Dr. Kristina Hendija explains,"It works for stress and anxiety relief for many. Cannabinoid receptors are present in all the brain regions responsible for processing anxiety and stress. Use of medical marijuana helps to dampen the severity that stressful events have on an individual. It helps form a regulatory buffer system against overwhelming emotional responses while also modulating the networks balancing distress and well-being. It should be known, however, that long term marijuana use with subsequent withdrawal can result in temporarily reduced dopamine levels."

3. Sleep

"Cannabis can help people sleep.," says Dr. Ingegno.

"CBD, the non-psychoactive compound, can help people sleep more soundly and delta 9-THC, the most commonly known psychoactive compound found in cannabis,  may help people fall asleep.  While there may be an entourage effect with many of the other cannabinoids and terpenes, the compounds that add the various flavors to the different strains, in general look for Indica-dominant varieties to help with sleep."

e-mail icon
Continue reading

Cannabis, Marijuana And Hemp — What Is The Difference, Exactly?

Cannabis sativa is a universal and versatile plant, so it’s no wonder that it has been given so many names throughout history and the world.

There are many names attributed to the plant that is scientifically known as cannabis sativa. From weed, to hemp, cannabis and marijuana, this seven-pointed leaf plant has a list of aliases that seems to grow as quickly as the plant itself. 

Many names linked to cannabis sativa refer to the same type of plant or product, but not all of these terms should be used interchangeably. In fact, cannabis, hemp and marijuana all refer to different products. It is critical to understand the difference as some of these products are fully legal while others are associated with possible felony offenses. 

Many cannabis enthusiasts understand the difference between cannabis, hemp and marijuana, but “a third of Americans think hemp and marijuana are the same thing, according to the National Institutes of Health, and many people still search Google to find out whether cannabidiol — a cannabis derivative known as CBD — will get them high,” according to The Conversation.

 

Photo by Catherine Falls Commercial/Getty Images

Cannabis 

Cannabis is an umbrella term of sorts. The word cannabis is an abbreviated name that comes from cannabis sativa, its scientific plant name. “The word “cannabis” refers to all products derived from the plant Cannabis sativa,” according to the U.S. Department of Health and Human Services. This means hemp is a form of cannabis, and marijuana is also a form of cannabis.

marijuana powder
Continue reading

Cannabis And Inflammation — What’s The Connection?

Cannabis works wonders for chronic inflammation but we are just now understanding why.

Regardless of how anyone feels about inflammation or the amount of pain it comes with, it remains an unavoidable healthy response that keeps us alive. From bruising a finger to the after-effects of cancer treatments, inflammation is the body's automatic response to every physical condition. There are times when inflammation could lead to extreme pain and adverse conditions due to a dysfunctional effect on the immune system. At this point, drugs are needed to reduce the pain and hasten to heal.

Recent studies show that cannabis could be an essential anti-inflammatory agent. Some medications have been tested and proven over the years to be effective against debilitating and extremely painful inflammations. However, better options are being sought for managing chronic conditions. Because most potent anti-inflammatory medications tend to have adverse side effects when used for long periods,

This piece investigates the potential of cannabis to serve as a panacea for chronic inflammation and autoimmune disorders. We investigate the relationship between cannabinoids, the endocannabinoid system, and these disorders mentioned above.

What Is Inflammation?

You can consider inflammation to be the body's way of fighting and protecting itself against harm. In this case, harm could mean an infection or injury within or outside the body. For instance, when you have an injury, the first thing you notice is that the affected area reddens and swells. This reaction is due to the immune system sending out a group of white blood cells to contain the bleeding and fight off any form of infection.

Within the body, this same reaction occurs around the vital organs and also in the blood vessels. Put simply; the immune system causes any part of the body at risk of being infected to be inflamed. The elderly deal with more chronic inflammation and use cannabis at a higher rate then early generations. 

e-mail icon
Continue reading

Capitalizing on CBD

It appears Pakistan may soon be entering the lucrative and growing global cannabis industry. Prime Minister Imran Khan’s government announced late last year that it would allow for the industrial production of hemp, a cannabis plant containing cannabidiol (CBD) that many experts believe has numerous therapeutic benefits and is generally sold in the form of gel capsules, gummies, oils, supplements, and extracts.

Unlike its cousin, marijuana, hemp does not contain significant quantities of the psychoactive component known as tetrahydrocannabinol (THC). THC is the compound most associated with the intoxicating effects of cannabis. Although hemp-derived CBD production in Pakistan would mostly be for export markets, its use domestically for medical purposes has been legal since September of 2020, meaning that new production could also service a growing domestic market.

More recently, Pakistan’s Minister of Science and Technology Shibli Faraz is reported to have told the National Assembly’s Standing Committee on Science and Technology that the government is set to introduce legislation to regulate the domestic cannabis industry imminently. This represents a huge economic opportunity for Pakistan as the country struggles to address its chronic current account deficit by boosting exports and diversifying its agricultural sector.

The use of CBD products related to health and wellness is set to experience exponential growth globally. This trend should be accelerated by the recent UN Commission on Narcotic Drugs (UNCND) decision to reclassify cannabis as a “therapeutic product.”

In a consumer report from 2019, researchers estimated that 64 million people in the United States had tried CBD within a year of the study. The CBD market is also just starting to grow in Europe well as in other regions such as South Asia, Southeast Asia, and Latin America. Fortune Business Insights recently reported that the global cannabinoid market is projected to grow from just under $3.7 billion in 2021 to approximately $58 billion by 2028, which represents a compound annual growth rate of 47 percent.

e-mail icon
Continue reading

Medicinal marijuana patients upset with current prices

Lafayette - It’s been a few years since the first medicinal marijuana products became available to patients in Louisiana and earlier this month the raw smokeable form was added to the list of available options.

But medicinal marijuana patients in the state are concerned about the pricing.

One of the biggest advocates of medicinal marijuana, senator and pharmacist Fred Mills said he hopes as time goes on prices will go down.

"My hope is that more production takes place, more consumption takes place, and then it’ll be volume-driven," he said.

Before HB391 was passed last summer by governor John Bel Edwards, the only options for medicinal marijuana patients were products like gummies, oils and tinctures.

Often times these products were pricey due to the processing it goes through.

e-mail icon
Continue reading

Researchers developing vaccine to fight opioid use disorder

A new vaccine being developed could be used to help those prone to Opioid Use Disorder and opiate addiction.

Scientists with a new research center at the University of Washington are working on a vaccine to help fight the opioid epidemic in a bid to stem the tide of overdose deaths that has swept the nation over the past two decades. 

Marco Pravetoni, the head of the new UW Medicine Center for Medication Development for Substance Use Disorders, is leading the effort to develop the vaccine. Similar to immunization against an invading pathogen, the vaccine under development would stimulate the body’s immune system to attack and destroy opioid molecules before they can enter the brain. 

Such a vaccine would not prevent drug cravings commonly experienced by those with opioid abuse disorder. But the treatment, if successful, would block the effects of opioids including euphoria, pain relief and even overdose, thus likely reducing abuse.

The new research center opened this month and has raised more than $2 million in initial funding. Pravetoni hopes to raise enough money to complete further research on the vaccine under development.

“What I’m hoping to achieve is pretty much every year, we’re going to start a new clinical trial,” Pravetoni told the Seattle Times in early January.

e-mail icon
Continue reading

Cannabis Remedies to Temper Certain Cold and Flu Symptoms

Therapeutic hemp and cannabis products to get you through the first bacterium equinox of 2022.

Whether you’re concerned about flu season or a protracted pestilence that has likely kept you masked and hypervigilant, if not in quarantine mode, a robust cannabis medicine cabinet can help you through the first bacterium equinox of 2022. Cannabis is by no means a cure-all, but you can use it to temper certain cold and flu symptoms much in the same way you might with an over-the-counter remedy—no astro traveling necessary. Furthermore, CBD acts as a unique immune system supporter, functioning as an anti-inflammatory, immunosuppressant and immunomodulator, conceivably keeping your immune responses evergreen (as in perennially resilient AF). For the uninitiated, just as recreational cannabis is more than skunky blunts and milky bong hits, contemporary therapeutic cannabis is much more than inky tinctures and skunky salves. In fact, therapeutic hemp can be delivered in a number of holistic, novel and cutting-edge ways. Here are some standouts from our own cannabis medicine cabinet.

 

1. Identity CBD Bone Broths

Mercer Island, Wash.-based wellness brand Identity produces a number of alternative CBD-infused products, including an obsession-worthy Norwegian bone broth packet infused with 10 mg Oregon hemp CBD. Each package contains enough canna-bone bouillon for a relatively rich mugful of aromatic broth or toothsome addition to a more complex soup recipe.

Officially, the packages are meant to be mixed with 1 cup of water for a potent stock, but when mixed with 1.5 cups of water are much more sippable as a straight-up broth. The broths come in three flavors: Chicken, Chanterelle Mushroom and Ginger Ramen, with the mushroom being my own personal sick day standout.

2. Green Heffa Fixitea

A soothing cup of tea is a sick day necessity; Green Heffa’s Fixitea Herbal “Steam” Blend is a peppermint panacea complete with soothing antiseptic, antibacterial and antimicrobial properties. Green Heffa is a family owned and operated farm, producing not just hemp cannabis, but all the botanicals in its teas. The brand’s founder, Farmer Cee, uses Indigenous, heritage farming techniques across Green Heffa’s 14 acres, even calling on the quilters of her hometown of Wilcox, Ala., to produce the brand’s vibrant, Afro-centric packaging. Each of the brand’s teas are built upon unique therapeutic botanical medleys, so if minty relief isn’t your bag, there are multiple other tableaus to choose from.

3. Elixinol Everyday Rapid Reset

The oil-based cannabis tincture is a ubiquitous medicine cabinet addition, but Elixinol’s Rapid Reset absorption-ready CBD liposome stands apart from most dispensary tinctures for its water solubility. That means this tincture—unlike its oilier counterparts—will blend as seamlessly with a glass of plain, flat water as it will with more texturally complex drinks like smoothies or frothy hot drinks. The 1 mg of CBD in each pump is a low enough dose for beginners or those with THC aversions. It’s also easily buildable for users with more established cannabinoid tolerances.

e-mail icon
Continue reading

Oregon State research shows hemp compounds prevent coronavirus from entering human cells

Hemp compounds identified by Oregon State University research via a chemical screening technique invented at OSU show the ability to prevent the virus that causes COVID-19 from entering human cells.

Findings of the study led by Richard van Breemen, a researcher with Oregon State’s Global Hemp Innovation Center, College of Pharmacy and Linus Pauling Institute, were published today in the Journal of Natural Products.

Hemp, known scientifically as Cannabis sativa, is a source of fiber, food and animal feed, and multiple hemp extracts and compounds are added to cosmetics, body lotions, dietary supplements and food, van Breemen said.

Van Breemen and collaborators, including scientists at Oregon Health & Science University, found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, blocking a critical step in the process the virus uses to infect people.

The compounds are cannabigerolic acid, or CBGA, and cannabidiolic acid, CBDA, and the spike protein is the same drug target used in COVID-19 vaccines and antibody therapy. A drug target is any molecule critical to the process a disease follows, meaning its disruption can thwart infection or disease progression.

e-mail icon
Continue reading

Marijuana users' risk of deadly complication doubles after rare type of bleeding stroke

Among people with an aneurysmal subarachnoid hemorrhage (aSAH) stroke, a type of bleeding stroke, recent marijuana users were more than twice as likely to develop a dangerous complication that can result in death or greater disability, according to new research published today in Stroke, a peer-reviewed journal of the American Stroke Association, a division of the American Heart Association.

The study is the largest to examine the impact of THC or Tetrahydrocannabinol, the psychoactive component (change of a person's mental state) of marijuana on complications after an aneurysmal subarachnoid hemorrhage (a severe form of stroke).
 
In an aneurysmal subarachnoid hemorrhage, a weakened and bulging part of a blood vessel bursts on the surface of the brain (called a ruptured aneurysm), resulting in bleeding in the space between the brain and the tissue that covers it. This type of stroke can be devastating, resulting in neurological disability in about 66% of people and death (during the follow up period) in about 40%. The immediate treatment of an aneurysmal subarachnoid hemorrhage focuses on stopping and preventing further bleeding. However, despite treatment, in the 14 days following an aneurysmal subarachnoid hemorrhage, many patients may develop worsening symptoms (such as speech problems or difficulty moving). This is caused by blood from the initial stroke irritating blood vessels, causing them to constrict enough to cut off the blood supply to a portion of the brain (called a vasospasm), resulting in more brain damage. This complication, called delayed cerebral ischemia, is a leading cause of death and disability after an aSAH stroke.

"We're all vulnerable to a bleeding stroke or a ruptured aneurysm, however, if you're a routine marijuana user, you may be predisposed to a worse outcome from a stroke after the rupture of that aneurysm," said Michael T. Lawton, M.D., senior author of the study and president and CEO of Barrow Neurological Institute in Phoenix, Arizona.

Researchers analyzed data on more than 1,000 patients who had been treated for aneurysmal subarachnoid hemorrhage at Barrow Neurological Institute between January 1, 2007 to July 31, 2019. All patients had been treated to stop the bleeding either via 1) open surgery to clip off the base of the aneurysm, or, 2) noninvasively, by threading a slim tube through a blood vessel to the base of the aneurysm and releasing coils that fold to fill in the space and provide a barrier to further bleeding.

Urine toxicology screening was performed on all patients admitted with ruptured aneurysms. The study compared the occurrence of delayed cerebral ischemia in 46 people (average age of 47 years; 41% female) who tested positive for THC (the component of cannabis, also known as marijuana, that induces a high) and 968 people (average age 56 years, 71% female) who tested negative for THC. A positive urine screen for THC reflects cannabis exposure within three days for a single use to within approximately 30 days for frequent heavy use.
 
The recent cannabis users did not have significantly larger aneurysms or worse stroke symptoms when admitted to the hospital, and they were not more likely to have high blood pressure or other cardiovascular risk factors than patients who screened negative for THC. However, recent cannabis users were significantly more likely to have also tested positive for other substances, including cocaine, methamphetamines and tobacco, compared to the patients who screened negative for THC.

Among all participants, 36% developed delayed cerebral ischemia; 50% were left with moderate to severe disability; and 13.5% died.

After adjusting for several patient characteristics as well as recent exposure to other illicit substances, patients who tested positive for THC at last follow up were found to be:

e-mail icon
Continue reading

WeedLife.com